Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Scemblix
Pharma
Novartis gears up for key expansions of 3 cancer drugs
Pluvicto, Ksiqali and Scemblix have key new indications lined up for them in earlier treatment settings. But they all slightly disappointed in Q1.
Angus Liu
Apr 23, 2024 3:37pm
Regulatory tracker: Bayer adds new Kerendia CV outcomes nod
Aug 29, 2022 9:48am
ASCO: Novartis eyes full nod for Gleevec follow-on Scemblix
May 26, 2022 5:00pm
Novartis wins CML nod for new Gleevec follow-on Scemblix
Nov 1, 2021 6:51am